We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
-14.15%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$69.6B
AUM Growth
-$16.5B
(-19%)
Cap. Flow
-$3.3B
Cap. Flow
% of AUM
-4.75%
Top 10 Holdings %
Top 10 Hldgs %
17.71%
Holding
779
New
83
Increased
294
Reduced
313
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$753M |
| 2 |
Marathon Petroleum
MPC
|
+$374M |
| 3 |
Target
TGT
|
+$361M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$299M |
| 5 |
Huntington Bancshares
HBAN
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ANDV
Andeavor
ANDV
|
+$1.05B |
| 2 |
Merck
MRK
|
+$702M |
| 3 |
Bank of America
BAC
|
+$542M |
| 4 |
Oracle
ORCL
|
+$528M |
| 5 |
Steel Dynamics
STLD
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.74% |
| 2 | Healthcare | 14.95% |
| 3 | Industrials | 13.38% |
| 4 | Technology | 12.24% |
| 5 | Energy | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
NetEase
NTES
$78.3B
| $122M | 0.18% |
2,597,825
+17,290
| +0.7% | +$780K |
|
152
Global Payments
GPN
$24.5B
| $122M | 0.18% |
+1,184,876
| New | +$131M |
|
|
IPG
153
DELISTED
Interpublic Group of Companies
IPG
| $122M | 0.18% |
5,911,557
+224,094
| +4% | +$5.12M |
|
154
Ambev
ABEV
$43.9B
| $121M | 0.17% |
30,869,575
-1,121,147
| -4% | -$4.79M |
|
155
Prologis
PLD
$135B
| $121M | 0.17% |
2,052,562
+52,143
| +3% | +$3.38M |
|
|
MRSH
156
Marsh
MRSH
$92.1B
| $119M | 0.17% |
1,497,306
-66,908
| -4% | -$5.58M |
|
|
WBC
157
DELISTED
WABCO HOLDINGS INC.
WBC
| $118M | 0.17% |
1,103,674
+28,781
| +3% | +$3.19M |
|
158
Lloyds Banking Group
LYG
$85.7B
| $118M | 0.17% |
46,257,484
-2,130,636
| -4% | -$6.06M |
|
159
Evergy
EVRG
$18.8B
| $117M | 0.17% |
2,066,259
+52,484
| +3% | +$3.03M |
|
160
Avery Dennison
AVY
$13.5B
| $117M | 0.17% |
+1,301,520
| New | +$123M |
|
161
Toll Brothers
TOL
$13.5B
| $117M | 0.17% |
+3,543,601
| New | +$114M |
|
|
PE
162
DELISTED
PARSLEY ENERGY INC
PE
| $115M | 0.16% |
7,182,821
-1,539,479
| -18% | -$35.1M |
|
|
FDC
163
DELISTED
First Data Corporation
FDC
| $114M | 0.16% |
6,747,625
+6,544,302
| +3,219% | +$128M |
|
164
Zimmer Biomet
ZBH
$19B
| $112M | 0.16% |
1,116,497
+475,107
| +74% | +$53.4M |
|
165
Omnicom Group
OMC
$24.3B
| $111M | 0.16% |
1,516,329
-17,586
| -1% | -$1.3M |
|
166
Flex
FLEX
$42.1B
| $111M | 0.16% |
19,281,027
-9,257,876
| -32% | -$64.7M |
|
|
MRO
167
DELISTED
Marathon Oil Corporation
MRO
| $110M | 0.16% |
7,651,796
-12,448,913
| -62% | -$222M |
|
168
Universal Health Services
UHS
$10B
| $108M | 0.16% |
929,515
-186,436
| -17% | -$23.4M |
|
169
Capital One
COF
$134B
| $105M | 0.15% |
1,391,062
-2,879,521
| -67% | -$249M |
|
170
Dick's Sporting Goods
DKS
$12B
| $104M | 0.15% |
3,324,592
+1,230,592
| +59% | +$42.8M |
|
171
World Kinect Corp
WKC
$1.81B
| $103M | 0.15% |
4,832,593
+63,612
| +1% | +$1.68M |
|
|
TRCO
172
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $103M | 0.15% |
2,265,135
+522,957
| +30% | +$21.2M |
|
173
Prudential Financial
PRU
$41.6B
| $103M | 0.15% |
1,257,457
-43,130
| -3% | -$3.97M |
|
174
Globe Life
GL
$13.4B
| $101M | 0.14% |
1,349,415
-273,521
| -17% | -$22.7M |
|
175
MetLife
MET
$61.4B
| $100M | 0.14% |
2,438,926
-130,082
| -5% | -$5.58M |
|
Similar funds
Boston Partners's Q4 2018 Portfolio in Review
As of Q4 2018, Boston Partners held 779 positions worth $69.6B, down 19% from $86.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Boston Partners withdrew a net $3.3B in Q4 2018, closing 76 positions and reducing 313 holdings. Its most notable exit was Andeavor, an estimated $1.05B position sold in full.
By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Boston Partners opened a new position in Procter & Gamble worth $775M.
- Boston Partners's largest Q4 2018 buy was Procter & Gamble: 8,428,522 shares worth $775M.
- Boston Partners added most to Marathon Petroleum in Q4 2018, an estimated $374M increase.
- Boston Partners's biggest Q4 2018 reduction was Merck, cutting an estimated $702M.
- Boston Partners fully exited Andeavor in Q4 2018, selling an estimated $1.05B.
- Boston Partners's ten largest holdings make up 18% of its $69.6B portfolio in Q4 2018.
- Boston Partners opened 83 new positions and closed 76 in Q4 2018.
- Boston Partners's portfolio value fell 19% quarter-over-quarter to $69.6B.
Based on Boston Partners's 13F filing for Q4 2018, filed 7 Feb 2019.